Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Potassium channel-blocking immunosuppressants from Merck & Co.

July 29, 1998

Novavax extends option agreement with Cantab

July 29, 1998

Scientists report success in achieving tolerance in transplantation models

July 22, 1998

Lisofylline development timetable readjusted, marketing agreements revised

July 22, 1998

Promising phase II results reported for BTI-322 in GVHD

July 21, 1998

Ribi acquires new adjuvant technology from U of Nebraska

July 21, 1998

Human vaccination study demonstrates potential of oral and nasal MaxVax

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Pasteur Merieux Connaught, Cistron Biotechnology collaborate on vaccine adjuvant development

July 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...